Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Nishi H, Gotoh K, Tomimaru Y, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Akita H, Asaoka T, Noda T, Takahashi H, Tanemura M, Doki Y, Eguchi H.
Nishi H, et al. Among authors: asaoka t.
Cancer Chemother Pharmacol. 2023 Oct;92(4):303-314. doi: 10.1007/s00280-023-04531-w. Epub 2023 Jul 26.
Cancer Chemother Pharmacol. 2023.
PMID: 37491611
Free PMC article.